| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 7 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. CRBP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $22.84M | - | |
| CEO | 188.2K | $1.83M | - | |
| CFO | 101.4K | $987.6K | - | |
| Other | 99.2K | $965.9K | - | |
| Other | 75.3K | $733.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 11, 2017 | Moran Sean F.61 | Chief Financial Officer | Buy | 3,300 | $6.14 | $20,262.00 | +1.0% | |
| May 11, 2017 | White Barbara | Chief Medical Officer | Buy | 2,435 | $6.12 | $14,904.64 | +1.5% | |
| May 11, 2017 | Cohen Yuval65 | Chief Executive Officer | Buy | 3,250 | $6.01 | $19,539.00 | +6.2% | |
| Mar 17, 2017 | White Barbara | Chief Medical Officer | Buy | 4,233 | $9.49 | $40,171.17 | +2.6% | |
| Mar 13, 2017 | Moran Sean F.61 | Chief Financial Officer | Buy | 2,000 | $9.60 | $19,200.00 | +0.6% | |
| Dec 2, 2016 | Moran Sean F.61 | Chief Financial Officer | Buy | 1,500 | $7.20 | $10,800.00 | +0.5% | |
| Nov 22, 2016 | Catlin Avery W | Director | Buy | 2,000 | $7.55 | $15,100.00 | +5.0% | |
| Nov 22, 2016 | Holmer Alan F | Director | Buy | 1,000 | $7.49 | $7,490.00 | +4.8% | |
| Nov 22, 2016 | White Barbara | Chief Medical Officer | Buy | 1,000 | $7.75 | $7,750.00 | +0.6% | |
| Nov 22, 2016 | Cohen Yuval65 | Chief Executive Officer | Buy | 1,340 | $7.64 | $10,237.60 | +11.7% |